Jilin Jian Yisheng Pharmaceutical Co Ltd
SZSE:002566
Income Statement
Earnings Waterfall
Jilin Jian Yisheng Pharmaceutical Co Ltd
Revenue
|
858.3m
CNY
|
Cost of Revenue
|
-252.2m
CNY
|
Gross Profit
|
606.1m
CNY
|
Operating Expenses
|
-509.6m
CNY
|
Operating Income
|
96.5m
CNY
|
Other Expenses
|
-15.2m
CNY
|
Net Income
|
81.2m
CNY
|
Income Statement
Jilin Jian Yisheng Pharmaceutical Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
633
N/A
|
644
+2%
|
674
+5%
|
672
0%
|
693
+3%
|
788
+14%
|
797
+1%
|
903
+13%
|
950
+5%
|
820
-14%
|
846
+3%
|
811
-4%
|
813
+0%
|
939
+16%
|
958
+2%
|
984
+3%
|
1 007
+2%
|
1 034
+3%
|
1 066
+3%
|
1 066
+0%
|
1 037
-3%
|
975
-6%
|
963
-1%
|
957
-1%
|
971
+1%
|
1 013
+4%
|
968
-4%
|
904
-7%
|
881
-3%
|
843
-4%
|
871
+3%
|
901
+3%
|
902
+0%
|
878
-3%
|
874
0%
|
851
-3%
|
827
-3%
|
830
+0%
|
855
+3%
|
871
+2%
|
858
-1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(192)
|
(170)
|
(186)
|
(179)
|
(179)
|
(253)
|
(264)
|
(319)
|
(322)
|
(229)
|
(236)
|
(203)
|
(207)
|
(280)
|
(262)
|
(263)
|
(269)
|
(286)
|
(289)
|
(291)
|
(279)
|
(239)
|
(238)
|
(230)
|
(236)
|
(260)
|
(253)
|
(240)
|
(240)
|
(217)
|
(235)
|
(248)
|
(254)
|
(221)
|
(240)
|
(238)
|
(230)
|
(215)
|
(251)
|
(258)
|
(252)
|
|
Gross Profit |
441
N/A
|
474
+7%
|
488
+3%
|
493
+1%
|
513
+4%
|
535
+4%
|
533
0%
|
584
+10%
|
628
+8%
|
591
-6%
|
611
+3%
|
608
0%
|
605
0%
|
659
+9%
|
696
+6%
|
721
+4%
|
738
+2%
|
748
+1%
|
777
+4%
|
775
0%
|
758
-2%
|
736
-3%
|
724
-2%
|
727
+0%
|
735
+1%
|
753
+2%
|
716
-5%
|
664
-7%
|
641
-3%
|
626
-2%
|
636
+2%
|
652
+3%
|
648
-1%
|
657
+1%
|
635
-3%
|
613
-3%
|
597
-3%
|
615
+3%
|
605
-2%
|
613
+1%
|
606
-1%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(366)
|
(411)
|
(420)
|
(422)
|
(443)
|
(441)
|
(438)
|
(467)
|
(504)
|
(552)
|
(566)
|
(610)
|
(615)
|
(618)
|
(640)
|
(646)
|
(642)
|
(621)
|
(647)
|
(637)
|
(632)
|
(607)
|
(605)
|
(602)
|
(613)
|
(625)
|
(582)
|
(553)
|
(521)
|
(506)
|
(508)
|
(526)
|
(521)
|
(524)
|
(510)
|
(484)
|
(478)
|
(509)
|
(494)
|
(505)
|
(510)
|
|
Selling, General & Administrative |
(365)
|
(411)
|
(420)
|
(422)
|
(440)
|
(440)
|
(437)
|
(462)
|
(503)
|
(528)
|
(554)
|
(600)
|
(605)
|
(593)
|
(608)
|
(619)
|
(612)
|
(604)
|
(645)
|
(633)
|
(624)
|
(596)
|
(595)
|
(594)
|
(607)
|
(608)
|
(581)
|
(547)
|
(523)
|
(496)
|
(513)
|
(530)
|
(520)
|
(502)
|
(509)
|
(486)
|
(479)
|
(488)
|
(497)
|
(508)
|
(514)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
(3)
|
(20)
|
0
|
0
|
(7)
|
(17)
|
(14)
|
(19)
|
(19)
|
(17)
|
(20)
|
(20)
|
(19)
|
(13)
|
(16)
|
(18)
|
(16)
|
(19)
|
(20)
|
(19)
|
(21)
|
(16)
|
(20)
|
(20)
|
(19)
|
|
Depreciation & Amortization |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(23)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(2)
|
(0)
|
0
|
(1)
|
(3)
|
(1)
|
(1)
|
(5)
|
(1)
|
(2)
|
(12)
|
(10)
|
(10)
|
(0)
|
(32)
|
(27)
|
(26)
|
19
|
(2)
|
(4)
|
(1)
|
24
|
5
|
11
|
13
|
21
|
19
|
15
|
21
|
24
|
22
|
22
|
15
|
19
|
20
|
21
|
22
|
19
|
23
|
23
|
23
|
|
Operating Income |
74
N/A
|
62
-17%
|
68
+9%
|
70
+3%
|
70
+0%
|
94
+35%
|
95
+0%
|
117
+24%
|
124
+6%
|
39
-69%
|
45
+15%
|
(3)
N/A
|
(10)
-304%
|
42
N/A
|
56
+35%
|
76
+35%
|
96
+27%
|
127
+33%
|
129
+1%
|
138
+7%
|
126
-9%
|
129
+2%
|
120
-7%
|
125
+4%
|
122
-3%
|
128
+5%
|
134
+5%
|
111
-17%
|
120
+8%
|
120
0%
|
129
+8%
|
126
-2%
|
127
+1%
|
133
+4%
|
125
-6%
|
129
+4%
|
120
-7%
|
106
-12%
|
110
+4%
|
108
-2%
|
96
-11%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
22
|
20
|
14
|
10
|
6
|
4
|
(3)
|
(16)
|
(26)
|
(35)
|
(39)
|
(37)
|
(35)
|
(34)
|
(32)
|
(31)
|
(29)
|
(26)
|
(25)
|
(24)
|
(23)
|
(22)
|
(22)
|
(20)
|
(18)
|
(17)
|
(15)
|
(14)
|
(11)
|
(10)
|
(8)
|
(6)
|
(7)
|
(4)
|
(4)
|
(3)
|
(2)
|
(3)
|
(1)
|
(0)
|
2
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
21
|
21
|
22
|
24
|
21
|
14
|
14
|
11
|
9
|
12
|
12
|
29
|
29
|
23
|
21
|
0
|
(1)
|
(3)
|
(7)
|
(5)
|
(6)
|
(5)
|
(7)
|
(4)
|
(3)
|
(3)
|
(4)
|
(6)
|
(7)
|
(5)
|
(6)
|
(5)
|
(5)
|
(5)
|
(2)
|
(3)
|
(2)
|
(1)
|
(4)
|
(4)
|
(4)
|
|
Pre-Tax Income |
118
N/A
|
102
-13%
|
104
+2%
|
104
0%
|
98
-6%
|
110
+13%
|
106
-4%
|
113
+7%
|
108
-4%
|
15
-86%
|
18
+14%
|
(10)
N/A
|
(16)
-59%
|
31
N/A
|
44
+45%
|
45
+1%
|
66
+48%
|
98
+48%
|
98
+0%
|
110
+12%
|
97
-11%
|
100
+3%
|
91
-9%
|
101
+11%
|
100
-1%
|
108
+8%
|
115
+6%
|
91
-21%
|
102
+11%
|
105
+3%
|
114
+9%
|
116
+1%
|
115
0%
|
123
+7%
|
118
-4%
|
123
+4%
|
116
-6%
|
101
-12%
|
104
+3%
|
103
-1%
|
95
-8%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(19)
|
(15)
|
(15)
|
(16)
|
(14)
|
(14)
|
(13)
|
(10)
|
(9)
|
(5)
|
(6)
|
(8)
|
(10)
|
(14)
|
(18)
|
(15)
|
(24)
|
(15)
|
(13)
|
(14)
|
(5)
|
(15)
|
(13)
|
(15)
|
(15)
|
(16)
|
(17)
|
(13)
|
(14)
|
(15)
|
(17)
|
(16)
|
(15)
|
(19)
|
(17)
|
(20)
|
(19)
|
(13)
|
(14)
|
(13)
|
(12)
|
|
Income from Continuing Operations |
99
|
88
|
89
|
88
|
83
|
96
|
93
|
103
|
99
|
11
|
11
|
(18)
|
(26)
|
17
|
27
|
30
|
43
|
83
|
86
|
95
|
92
|
85
|
78
|
86
|
85
|
92
|
98
|
78
|
88
|
90
|
98
|
100
|
100
|
105
|
101
|
103
|
96
|
88
|
90
|
90
|
83
|
|
Income to Minority Interest |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
1
|
0
|
0
|
(1)
|
(3)
|
(4)
|
(10)
|
(12)
|
(16)
|
(23)
|
(24)
|
(25)
|
(23)
|
(16)
|
(12)
|
(17)
|
(14)
|
(16)
|
(17)
|
(9)
|
(12)
|
(10)
|
(11)
|
(11)
|
(9)
|
(9)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(4)
|
(1)
|
|
Net Income (Common) |
98
N/A
|
87
-11%
|
89
+2%
|
88
-1%
|
83
-6%
|
96
+16%
|
93
-3%
|
103
+10%
|
100
-3%
|
11
-89%
|
11
+5%
|
(19)
N/A
|
(29)
-49%
|
13
N/A
|
17
+30%
|
18
+3%
|
26
+48%
|
60
+130%
|
62
+3%
|
70
+13%
|
69
-1%
|
69
0%
|
66
-5%
|
70
+7%
|
71
+2%
|
77
+7%
|
81
+6%
|
70
-15%
|
76
+9%
|
80
+6%
|
86
+8%
|
89
+3%
|
91
+3%
|
96
+5%
|
95
-1%
|
98
+3%
|
91
-7%
|
83
-9%
|
85
+2%
|
87
+3%
|
81
-6%
|
|
EPS (Diluted) |
0.3
N/A
|
0.26
-13%
|
0.27
+4%
|
0.27
N/A
|
0.26
-4%
|
0.29
+12%
|
0.29
N/A
|
0.31
+7%
|
0.3
-3%
|
0.03
-90%
|
0.03
N/A
|
-0.06
N/A
|
-0.09
-50%
|
0.04
N/A
|
0.06
+50%
|
0.06
N/A
|
0.08
+33%
|
0.18
+125%
|
0.18
N/A
|
0.21
+17%
|
0.21
N/A
|
0.21
N/A
|
0.2
-5%
|
0.21
+5%
|
0.22
+5%
|
0.23
+5%
|
0.24
+4%
|
0.2
-17%
|
0.21
+5%
|
0.24
+14%
|
0.25
+4%
|
0.26
+4%
|
0.27
+4%
|
0.29
+7%
|
0.29
N/A
|
0.3
+3%
|
0.28
-7%
|
0.25
-11%
|
0.26
+4%
|
0.26
N/A
|
0.25
-4%
|